Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries

BACKGROUND: Hepatitis C virus (HCV) infection is the leading cause of cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC) worldwide. In Europe, people who inject drugs (PWID) represent the majority of HCV infections, but are often excluded from treatment. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Maticic, Mojca, Zorman, Jerneja Videcnik, Gregorcic, Sergeja, Schatz, Eberhard, Lazarus, Jeffrey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509821/
https://www.ncbi.nlm.nih.gov/pubmed/31072401
http://dx.doi.org/10.1186/s12954-019-0303-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509821/
https://www.ncbi.nlm.nih.gov/pubmed/31072401
http://dx.doi.org/10.1186/s12954-019-0303-9

Ejemplares similares